Overexpression of the STRAP long isoform resulted in a significant increase in late CD71–CD235a+ erythroblasts (to 6.5% to 14.1%, i.e., a 1.59- to 2.53-fold increase) on day 14 in the three U2AF1S34F MDS patients compared with the EV control (Figure 7I). Here, TFRC is linked to myelodysplastic syndrome.